Serological abnormalities in bird fancier's lung: Author's reply

Por Udwadia, Zarir F
Publicado em 1990

Disseminated tuberculosis with immune thrombocytopenic purpura

Por Dagaonkar, Rucha S., Udwadia, Zarir F.
Publicado em 2012

Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai

Por Udwadia, Zarir F., Moharil, Gautam
Publicado no Lung India (2014)

Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?

Por Pinto, Lancelot M, Udwadia, Zarir F
Publicado em 2010

How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus

Por Udwadia, Zarir F., Raju, Reyma Sara
Publicado no Med J Armed Forces India (2020)

The N-95 mask: Invaluable ally in the battle against the COVID-19 pandemic

Por Udwadia, Zarir F., Raju, Reyma Sara
Publicado no Lung India (2020)

Oxaliplatin-induced lung fibrosis

Por Shah, Arpan, Udwadia, Zarir F., Almel, Sachin
Publicado em 2009

Favipiravir: A new and emerging antiviral option in COVID-19

Por Agrawal, Umang, Raju, Reyma, Udwadia, Zarir F.
Publicado no Med J Armed Forces India (2020)

Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?

Por Udwadia, Zarir F., Pinto, Lancelot M., Uplekar, Mukund W.
Publicado em 2010

Tropical pulmonary eosinophilia - A review

Por Mullerpattan, Jai B., Udwadia, Zarir F., Udwadia, Farokh E.
Publicado em 2013

Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us

Por Intini, Enrica, Kishore, Girija, Richeldi, Luca, Udwadia, Zarir F
Publicado no BMJ Case Rep (2019)

Safety of Rifabutin in patients with rifampicin-induced thrombocytopenia

Por Sarkar, Trina, Riccardi, Niccolò, Wagh, Haresh, Udwadia, Zarir F
Publicado no Lung India (2020)

Primary immune deficiency in the intensive care unit: It is never too late to diagnose and treat

Por Dagaonkar, Rucha S., Sen, Tiyas, Udwadia, Zarir F., Desai, Mukesh B.
Publicado em 2011

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis

Por Udwadia, Zarir F., Mullerpattan, Jai B., Balakrishnan, Canchi, Richeldi, Luca
Publicado no Lung India (2015)

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai

Por Udwadia, Zarir F, Mullerpattan, Jai Bharat, Shah, Kushal D, Rodrigues, Camilla S
Publicado no Lung India (2016)

Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China

Por Richeldi, Luca, Rubin, Adalberto Sperb, Avdeev, Sergey, Udwadia, Zarir F., Xu, Zuo Jun
Publicado no BMC Med (2015)

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic

Por Udwadia, Zarir F., Tornheim, Jeffrey A., Ganatra, Shashank, DeLuca, Andrea, Rodrigues, Camilla S., Gupta, Amita
Publicado no BMC Infect Dis (2019)

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience

Por Mullerpattan, Jai B, Porwal, Sana H, Sarkar, Trina A, Wagh, Haresh D, Udwadia, Zarir F
Publicado no Lung India (2019)

COVID-19 -Tuberculosis interactions: When dark forces collide

Por Udwadia, Zarir F., Vora, Agam, Tripathi, Awatansh R., Malu, Ketan N., Lange, Christoph, Sara Raju, Reyma
Publicado no Indian J Tuberc (2020)

Response to the comments received on article “Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, compar...

Por Udwadia, Zarir F., Barkate, Hanmant, Patil, Saiprasad, Rangwala, Shabbir, Wu, Wen, Caracta, Cynthia F., Tandon, Monika
Publicado no Int J Infect Dis (2021)